Here are five insights from a new Kalorama Information Report into the global neurostimulation device market:
1. Neurostimulation is often associated with use in pain relief or therapy.
2. Neurostimulation is naturally segmented into two classifications — the devices that use external electrodes and those that use internal, or implanted, electrodes.
3. The two common external electrode methods are electromuscular stimulation and transcutaneous electrical nerve stimulation. Spinal cord stimulation and vagus nerve stimulation rely on implanted electrodes.
4. The global neurostimulation device market includes a number of individual market segments such as deep brain stimulation, sacral nerve stimulation and spinal cord stimulation.
5. Key players in the market include Boston Scientific, Cochlear, Cyberonics, St. Jude Medical and Medtronic.
More articles on devices:
OrthAlign grew 46% in 2014 — 5 things to know
Medtronic-Covidien deal final — but how will it change the industry? 7 thoughts
OSU Wexner Medical Center physicians 1st to implant plastic device for cartilage damage